BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1585@azbio.org DTSTART;TZID=America/Phoenix:20211004T173000 DTEND;TZID=America/Phoenix:20211004T183000 DTSTAMP:20210913T231702Z URL:https://www.azbio.org/events/leading-women-biotech-and-beyond-2 SUMMARY:Leading Women: Biotech and Beyond - - 4 Oct 21 17:30 DESCRIPTION:\nJoin us to kick off Arizona Bioscience Week. \; \;\nL eading Women: Biotech and Beyond.\nA stimulating conversation with some of biotech’s leading women. \;  \;  \;\nDate: \; Monday\, October 4\, 2021 \;  \; Time: \; 5:30 PM - 6:30 PM\n\nLocation : \; \;Zoom\nThis is a free community event. \; \;Registra tion is required.\n\n2021 Leading Women Panelists:\nHelen Goldstein | Perk ins Coie LLP (Moderator)\n\nHelen Goldstein focuses on corporate law\, mer gers and acquisitions\, and securities. She maintains a general cross-indu stry practice\, but has experience advising companies that transact in hig hly regulated or intellectual property rich environments such as the pharm aceutical industry.\n\nHer work at Perkins Coie focuses on Corporate &\ ; Securities\, Emerging Companies &\; Venture Capital Law\, and Technol ogy Transactions &\; Privacy Law with companies in the Healthcare\, Bio technology &\; Pharmaceutical industries. \;\n\nShe is a graduate o f the \;Arizona State University\, Sandra Day O'Connor College of Law\ , J.D.\, magna cum laude and University of Nottingham\, LL.B.\, with honor s. Learn more about Helen\n\nJennifer K. Barton\, PhD\, The University of Arizona\n\n\n\nJennifer Barton\,  \;PhD Is the director of the BIO5 In stitute at the University of Arizona. \; BIO5 is celebrating its 20th Anniversary in 2021. \; Dr. Barton  \;is known for her development of miniature endoscopes that combine multiple optical imaging techniques\ , particularly optical coherence tomography and fluorescence spectroscopy. She evaluates the suitability of these endoscopic techniques for detectin g early cancer development in patients and pre-clinical models. She has a particular interest in the early detection of ovarian cancer\, the most de adly gynecological malignancy. Additionally\, her research into light-tiss ue interaction and dynamic optical properties of blood laid the groundwork for a novel therapeutic laser to treat disorders of the skin’s blood ve ssels. She has published over 100 peer-reviewed journal papers in these re search areas. Dr. Barton has served as a member of the AZBio Board of Dire ctors since 2014. Learn more about Jennifer\n\nAnvita Gupta\, AINovo™ Bi otech\, Inc. \;\n\n\n\nAnvita Gupta is CEO of AINovo™ Biotech\, Inc. Anvita has more than nine years of experience in artificial intelligence domains\, including generative modeling\, computer vision\, and natural la nguage processing for genomics\, proteomics\, and drug design for global a cademic labs at Stanford University\, Harvard Medical School\, and ETH Zur ich. \;In 2015\, Anvita was invited to present her research on AI for drug discovery to President Obama at the White House\, and presented the a pplications to the Ebola pandemic at the White House Ebola Innovators Conf erence hosted by USAID and OSTP. \;Her research in generative modeling and protein design has been published in journals such as Wiley’s Molec ular Informatics and Nature Machine Intelligence\, and she has delivered t alks at international conferences including ICML\, ISMB\, BIO\, TEDx Redmo nd\, and the ITC International Conclave. \;Anvita received her M.Sc an d B.Sc with honors in Computer Science from Stanford University specializi ng in Artificial Intelligence and Biocomputation.\n\nCathy Langham | Langh am Logistics\n\nCathy Langham opened trucking and air freight franchises 3 years out of college\, then sold them and co-founded Langham Logistics\, Inc. with her sister and brother.  \;Langham is now a $55+ million glo bal transportation and warehousing business with 180 employees and distrib ution facilities across the United States. \; Ms. Langham shares her l ogistics expertise with business leaders in industries including pharmaceu tical\, food and beverage\, automotive\, and other sectors with complex su pply chains. Cathy is the logistics company’s President and CEO and spen ds much of her time focused on strategic direction\, customer relationship s\, and civic leadership. \; Cathy joined the AZBio Board of Directors in January of 2021. Learn more about Cathy\n\nKathryn Sykes\, PhD\, \ ; Calviri\, Inc.\n\nKathryn Sykes\, PhD is Vice President\, \; Researc h &\; Product Development at Calviri\, Inc. \; The company's missio n is to provide affordable products worldwide that will end deaths from ca ncer by combining a unique\, highly immunogenic source of neoantigens with a peptide array platform. Calviri will develop new diagnostic and therape utic products\, and then preventative vaccines that will stop cancer from starting.\n\nKathryn Sykes has decades of experience inventing and develop ing innovative molecular\, genetic and biochemical technologies to manipul ate the immune system towards better health. She grew the labs at HealthTe ll and served as V.P. of Research. Previously\, she was a professor in the School of Life Sciences at the Biodesign Institute at Arizona State Unive rsity. At the University of Texas Southwestern Medical School she pursued technologies that became the basis of a Texas biotechnology company\, ulti mately acquired by Macrogenics. Dr. Sykes received her B.S. in Biology and Economics from Duke University and her Ph.D. in Biochemistry and Genetics from Duke University Medical Center. END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20201004T173000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR